NCT04785911View on ClinicalTrials.gov

Use of the Modified PUQE Score on Admitted Cases of Hyperemesis Gravidarum (HG) to Guide Response to Treatment

CompletedOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

September 5, 2021

Primary Completion Date

October 1, 2022

Study Completion Date

November 1, 2022

Conditions

Hyperemesis Gravidarum

Interventions

DRUG

Antiemetic Combinations

Evaluation of response to treatment of hyperemisis gravidarum (antiemetics and other methods ) by PUQE score

Trial Locations (1)

71684

Tasnem iIbrahem Aboelouon, Asyut

All Listed Sponsors

collaborator

Assiut University

OTHER

lead

Tasnem Abo-elouon

OTHER

NCT04785911 - Use of the Modified PUQE Score on Admitted Cases of Hyperemesis Gravidarum (HG) to Guide Response to Treatment | Biotech Hunter | Biotech Hunter